Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Sonia Philipose Sonia Philipose |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2015

Originalarbeit (Zeitschrift)

** Pasterk, L; Philipose, S; Eller, K; Marsche, G; Heinemann, A; Schuligoi, R The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions.
Pharmacology. 2015; 96(3-4):137-143 Doi: 10.1159/000437143
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Konya, V; Üllen, A; Kampitsch, N; Theiler, A; Philipose, S; Parzmair, GP; Marsche, G; Peskar, BA; Schuligoi, R; Sattler, W; Heinemann, A Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
J Allergy Clin Immunol. 2013; 131(2):532-40.e1-532-40.e2 Doi: 10.1016/j.jaci.2012.05.008
Web of Science PubMed FullText FullText_MUG

 

** Sreckovic, I; Birner-Gruenberger, R; Obrist, B; Stojakovic, T; Scharnagl, H; Holzer, M; Scholler, M; Philipose, S; Marsche, G; Lang, U; Desoye, G; Wadsack, C Distinct composition of human fetal HDL attenuates its anti-oxidative capacity.
Biochim Biophys Acta. 2013; 1831(4):737-746 Doi: 10.1016/j.bbalip.2012.12.015 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Philipose, S; Konya, V; Lazarevic, M; Pasterk, LM; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
PLoS One. 2012; 7(8):e40222-e40222 Doi: 10.1371/journal.pone.0040222 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Konya, V; Philipose, S; Bálint, Z; Olschewski, A; Marsche, G; Sturm, EM; Schicho, R; Peskar, BA; Schuligoi, R; Heinemann, A Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
Eur J Immunol. 2011; 41(8):2379-2389 Doi: 10.1002/eji.201141460 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Luschnig-Schratl, P; Sturm, EM; Konya, V; Philipose, S; Marsche, G; Fröhlich, E; Samberger, C; Lang-Loidolt, D; Gattenlöhner, S; Lippe, IT; Peskar, BA; Schuligoi, R; Heinemann, A EP4 receptor stimulation down-regulates human eosinophil function.
Cell Mol Life Sci. 2011; 68(21): 3573-3587. Doi: 10.1007/s00018-011-0642-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Mashta, A; Mishra, P; Philipose, S; Tamilzhalagan, S; Mahmud, H; Bhaskar, S; Upadhyay, P Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory.
J Negat Results Biomed. 2011; 10(7):16-16 Doi: 10.1186/1477-5751-10-16 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Philipose, S; Offner, M; Konya, V; Heinemann, A; Schuligoi, R PGE2 INHIBITS THROMBOGENESIS VIA THE EP4 RECEPTOR IN A PROTEIN KINASE C MEDIATED PATHWAY
BASIC CLIN PHARMACOL. . 2011; 109: 98-98.-10th Congress of the European Association for Clinical Pharmacology and Therapeutics; JUN 26-29, 2011; Budapest, HUNGARY. [Poster]
Web of Science

 

** Sreckovic, I; Birner-Gruenberger, R; Philipose, S; Holzer, M; Marsche, G; Desoye, G; Lang, U; Wadsack, C APOLIPOPROTEINS (APO) ACCOUNTS FOR THE ANTI-INFLAMMATORY FUNCTION OF FETAL HDL
PLACENTA. 2011; 32(9):A112-A112.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 14-17, 2011; Geilo, NORWAY. [Poster]
Web of Science

 

2010

Originalarbeit (Zeitschrift)

** Philipose, S; Konya, V; Sreckovic, I; Marsche, G; Lippe, IT; Peskar, BA; Heinemann, A; Schuligoi, R The Prostaglandin E2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation.
Arterioscler Thromb Vasc Biol. 2010; 30(12): 2416-2423. Doi: 10.1161/ATVBAHA.110.216374 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schuligoi, R; Sturm, E; Luschnig, P; Konya, V; Philipose, S; Sedej, M; Waldhoer, M; Peskar, BA; Heinemann, A CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Pharmacology. 2010; 85(6): 372-382. Doi: 10.1159/000313836 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum